← All candidates
Eight insider buys in the last year — $42.37M in all.
64 filings on record.
ATTOAttovia Therapeutics, Inc.
NasdaqGM · Healthcare · $1.08B
$24.52
+7.59% · Sep 14
Eight insider buys in the last year — $42.37M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 8 buys● 46 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.08B
Float
26.3M
58% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
601.1
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Walsh Colin
Bought $8.50M on Aug 6 — 500,000 sh @ $17.00, held indirect, 17% of their stake.
No completed positions to measure
Insider
Goldman Sachs Group Inc
Bought $8.50M on Aug 6 — 500,000 sh @ $17.00, held indirect, 17% of their stake.
0 of 1 position beat the S&P
10% owner
Redmile Group, LLC
Bought $6.80M on Aug 6 — 400,000 sh @ $17.00, held indirect, 34% of their stake.
No completed positions to measure
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
59 more transactions on Pro →Context
Wall St
$42.20 avg target
+72.1% vs today · 5 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 1 quarters beat
Q2 '26−$4.88 act−$0.26
Coverage
Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC SaysMT Newswires · 2w agoMeet Attovia: The Clinical-Stage Biotech That Aims to Stop Chronic Itch at the Source24/7 Wall St. · 4w agoDeere upgraded, Lumentum initiated: Wall Street's top analyst callsThe Fly · 2w agoHere Are Monday’s Top Wall Street Analyst Research Calls: AGCO Corporation, Deere & Co., Edison International, Lumentum Holdings, PG&E, Sempra Energy, STAG Industrial, Ticketplus, and More24/7 Wall St. · 2w ago
The file stays open
64 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice